$236M
$0
0.0% of portfolio
21
Q2 2024
New
$903M
$11,000
0.0% of portfolio
1,260
Q2 2025
Reduced 43.19%
$2.85B
$33,000
0.0% of portfolio
643
Q2 2025
Reduced 19.93%
$1.33B
$11,000
0.0% of portfolio
1,343
Q2 2025
Reduced 2.47%
$3.69B
$165,000
0.0% of portfolio
1,261
Q2 2025
Reduced 6.59%
$5.68B
$286,000
0.0% of portfolio
5,168
Q2 2025
Added 275.31%
$1.59B
$15,000
0.0% of portfolio
757
Q2 2025
Added 290.21%
$8.85B
$135,000
0.0% of portfolio
604
Q2 2025
Reduced 9.72%
$16.4B
$799,000
0.0% of portfolio
10,869
Q2 2025
Reduced 13.94%
$389M
$2,000
0.0% of portfolio
66
Q1 2025
Added 725.0%
$1.96B
$343,000
0.0% of portfolio
12,519
Q2 2025
Reduced 26.21%
-
$0
0.0% of portfolio
-
Q2 2025
Added 35.61%
$259M
$91,000
0.0% of portfolio
11,684
Q2 2025
Reduced 34.65%
$8.77B
$295,000
0.0% of portfolio
6,882
Q2 2025
Added 4.65%
$374M
$4,000
0.0% of portfolio
2,693
Q2 2025
Reduced 67.6%
$903M
$4,000
0.0% of portfolio
73
Q1 2025
Reduced 40.65%
$34.2B
$700,000
0.0% of portfolio
4,447
Q2 2025
Reduced 65.87%
$2.26B
$541,000
0.0% of portfolio
17,947
Q2 2025
Reduced 1.97%
$92.3M
$2,000
0.0% of portfolio
704
Q2 2025
Reduced 52.88%
$170M
$1,000
0.0% of portfolio
2,051
Q2 2025
Reduced 15.18%
$0
$402,000
0.0% of portfolio
15,300
Q4 2023
Added 80.0%
$0
$254,000
0.0% of portfolio
1,500
Q2 2020
New
$0
$283,000
0.0% of portfolio
6,620
Q2 2025
Reduced 60.17%
$0
$48,000
0.0% of portfolio
1,100
Q2 2025
Added 39.24%
$0
$169,000
0.0% of portfolio
4,000
Q2 2025
Added 2.56%
$0
$359,000
0.0% of portfolio
6,600
Q2 2025
Reduced 44.54%
$0
$28,000
0.0% of portfolio
500
Q4 2021
Reduced 77.27%
$0
$722,000
0.0% of portfolio
18,200
Q2 2025
Reduced 41.1%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 8.81%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 25.69%
$361M
$19,000
0.0% of portfolio
1,939
Q2 2025
Added 959.56%
$691M
$3,000
0.0% of portfolio
130
Q2 2025
Added 9.24%
$5.36B
$132,000
0.0% of portfolio
1,008
Q2 2025
Added 20.0%
$827M
$13,000
0.0% of portfolio
1,498
Q2 2025
Added 253.3%
$2.65B
$328,000
0.0% of portfolio
19,005
Q2 2025
Reduced 32.08%
$2.05B
$156,000
0.0% of portfolio
1,377
Q2 2025
Reduced 3.71%
$180M
$2,000
0.0% of portfolio
143
Q2 2025
New
$420M
$185,000
0.0% of portfolio
10,627
Q2 2025
Added 14,659.72%
$326M
$26,000
0.0% of portfolio
7,070
Q2 2025
Added 109.79%
-
$0
0.0% of portfolio
-
Q2 2025
Added 0.3%
-
$0
0.0% of portfolio
-
Q2 2025
Added 27.66%
$1.16B
$7,000
0.0% of portfolio
753
Q2 2025
Added 173.82%
$991M
$40,000
0.0% of portfolio
1,770
Q1 2025
Reduced 85.08%
$1.47B
$10,000
0.0% of portfolio
1,320
Q2 2025
Added 70.32%
-
$0
0.0% of portfolio
-
Q2 2025
New
$52B
$22,000
0.0% of portfolio
680
Q2 2025
Reduced 38.18%
$522M
$14,000
0.0% of portfolio
3,643
Q2 2025
Added 3,040.52%
$1.66B
$28,000
0.0% of portfolio
6,674
Q2 2025
Reduced 59.64%
$4.01B
$992,000
0.0% of portfolio
7,894
Q2 2025
Added 5.37%
$288M
$12,000
0.0% of portfolio
700
Q1 2025
Reduced 1.41%